NHL Charts, page-70

It's in the Annual Report (page 5) released last Thursday.

I don't think 5.8c will be the top while comparing with RAP, PCK and Akili.

Just have a close look at Akili, also developing an app to target aged 8 - 12, still not received FDA approval yet, but raised US$140m over last few years. Akili does have another three apps in developments, one at advantage stage, other two at early stage. Based on Akili valuation, I guess NHL could be valued at $100m or more, as it received FDA approval and CE mark, (targeting aged 3 - 8), with two apps, TAli Train & TAli Detect, one therapy and one screening test.

All imo.